TEVA 5506 Pill — YELLOW CAPSULE, 16mm — Fluoxetine
| Imprint | TEVA / 5506 |
|---|---|
| Colour | YELLOW |
| Shape | CAPSULE |
| Size | 16 |
| Strength | OLANZAPINE 12 mg;FLUOXETINE HYDROCHLORIDE 25 mg |
| Dosage form | Capsule |
| Manufacturer | Teva Pharmaceuticals USA, Inc. |
| NDC | 0093-5506 |
| Schedule | — |
| Availability | Prescription only |
| Ingredients | OLANZAPINE[OLANZAPINE];FLUOXETINE HYDROCHLORIDE[FLUOXETINE] |
What does this imprint mean?
The imprint "TEVA 5506" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.
Active ingredient
Fluoxetine
Uses and warnings
BOXED WARNING: BOXED WARNING - Suicidal Thoughts and Behaviors: "Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies." Monitoring is required for all ages starting antidepressant therapy. "Fluoxetine is not approved for use in children less than 7 years of age." Key Warnings Include: - Serotonin syndrome risk when combined with other serotonergic drugs - Allergic reactions and rash (discontinue if occurs) - Activation of mania/hypomania in bipolar patients - Seizure risk in predisposed individuals - Weight loss and appetite changes - Abnormal bleeding (especially with NSAIDs/warfarin) - Angle-closure glaucoma in susceptible patients - Hyponatremia/SIADH - QT interval prolongation - Cognitive and motor impairment potential --- | BOXED WARNING - Suicidal Thoughts and Behaviors: "Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies." Monitoring is required for all ages starting antidepressant therapy. "Fluoxetine is not approved for use in children less than 7 years of age." Key Warnings Include: - Serotonin syndrome risk when combined with other serotonergic drugs - Allergic reactions and rash (discontinue if occurs) - Activation of mania/hypomania in bipolar patients - Seizure risk in predisposed individuals - Weight loss and appetite changes - Abnormal bleeding (especially with NSAIDs/warfarin) - Angle-closure glauc
Fluoxetine is indicated for: - "Acute and maintenance treatment of Major Depressive Disorder" - "Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD)" - "Acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe Bulimia Nervosa" - "Acute treatment of Panic Disorder, with or without agoraphobia" ---
How to identify this pill
- • Check the imprint matches exactly: "TEVA 5506".
- • Confirm the colour (YELLOW) and shape (CAPSULE).
- • Compare the size (16) against a ruler if possible.
- • When in doubt, confirm with a pharmacist before taking any medication.
Similar-looking pills
CIS28
YELLOW CAPSULE · Folic Acid
0 8
YELLOW CAPSULE · Mirtazapine
IGand342
YELLOW CAPSULE · Naproxen
ASC 106
YELLOW CAPSULE · Benzonatate
200 XR
YELLOW CAPSULE · Quetiapine
ASC 106
YELLOW CAPSULE · Benzonatate
A 48
YELLOW CAPSULE · Metformin
104
YELLOW CAPSULE · Gabapentin
IP102
YELLOW CAPSULE · Gabapentin
AMOX 500
YELLOW CAPSULE · Amoxicillin
AMOX 500
YELLOW CAPSULE · Amoxicillin
AMOX 500
YELLOW CAPSULE · Amoxicillin
Other pills of Fluoxetine
SG 114
BLUE;GREEN CAPSULE · Fluoxetine
20mg
BLUE CAPSULE · Fluoxetine
FLUOXETINE 20
BLUE CAPSULE · Fluoxetine
251 par
YELLOW;GRAY CAPSULE · Fluoxetine
SG 114
GREEN CAPSULE · Fluoxetine
PLIVA 648
WHITE;GREEN CAPSULE · Fluoxetine
E 92
GREEN;ORANGE CAPSULE · Fluoxetine
R 0150
BLUE OVAL · Fluoxetine
FL 10
WHITE OVAL · Fluoxetine
DISTA 3107
ORANGE;GREEN CAPSULE · Fluoxetine
40 A107
BLUE CAPSULE · Fluoxetine
PLIVA 648
WHITE;GREEN CAPSULE · Fluoxetine
Official references
Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file d5f35371-be0b-4d03-b833-d3d826781dd2.xml